Ron Bentsur - Sep 28, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Sep 28, 2022
Transactions value $
$7,345
Form type
4
Date filed
10/3/2022, 08:16 AM
Previous filing
Sep 27, 2022
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $3.62K +500 +0.02% $7.23 3.01M Sep 28, 2022 Direct F1
transaction NVCT Common Stock Purchase $3.73K +500 +0.02% $7.46 3.01M Sep 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.